The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antibiotics: past, present and future
Open accessAbstract
The first antibiotic, salvarsan, was deployed in 1910. In just over 100 years antibiotics have drastically changed modern medicine and extended the average human lifespan by 23 years. The discovery of penicillin in 1928 started the golden age of natural product antibiotic discovery that peaked in the mid-1950s. Since then, a gradual decline in antibiotic discovery and development and the evolution of drug resistance in many human pathogens has led to the current antimicrobial resistance crisis. Here we give an overview of the history of antibiotic discovery, the major classes of antibiotics and where they come from. We argue that the future of antibiotic discovery looks bright as new technologies such as genome mining and editing are deployed to discover new natural products with diverse bioactivities. We also report on the current state of antibiotic development, with 45 drugs currently going through the clinical trials pipeline, including several new classes with novel modes of action that are in phase 3 clinical trials. Overall, there are promising signs for antibiotic discovery, but changes in financial models are required to translate scientific advances into clinically approved antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline
Blin, K., Shaw, S., Steinke, K., Villebro, R., Ziemert, N., Lee, S. Y., Medema, M. H., & Weber, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz310 · Cited by 2,907
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Fleming, A. (1929) · PubMed Central · Cited by 1,647
Natural product discovery: past, present, and future
Katz, L., & Baltz, R. H. (2016) · Journal of Industrial Microbiology and Biotechnology · doi:10.1007/s10295-015-1723-5 · Cited by 1,144
Discovery of microbial natural products by activation of silent biosynthetic gene clusters
Rutledge, P. J., & Challis, G. L. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3496 · Cited by 986
Human commensals producing a novel antibiotic impair pathogen colonization
Zipperer, A., Konnerth, M. C., Laux, C., Berscheid, A., Janek, D., Weidenmaier, C., Burian, M., Schilling, N. A., Slavetinsky, C., Marschal, M., et al. (2016) · Nature · doi:10.1038/nature18634 · Cited by 938
Alternatives to antibiotics—a pipeline portfolio review
Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V. A., Foster, S., Gilmore, B. F., Hancock, R. E. W., Harper, D., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00466-1 · Cited by 848
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Use of Ichip for High-Throughput In Situ Cultivation of “Uncultivable” Microbial Species
Nichols, D., Cahoon, N., Trakhtenberg, E. M., Pham, L., Mehta, A., Belanger, A., Kanigan, T., Lewis, K., & Epstein, S. S. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01754-09 · Cited by 732
Donia, M. S., Cimermancic, P., Schulze, C. J., Wieland Brown, L. C., Martin, J., Mitreva, M., Clardy, J., Linington, R. G., & Fischbach, M. A. (2014) · Cell · doi:10.1016/j.cell.2014.08.032 · Cited by 705
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Fragments of the earliest land plants
Wellman, C. H., Osterloff, P. L., & Mohiuddin, U. (2003) · Nature · doi:10.1038/nature01884 · Cited by 606
An environmental bacterial taxon with a large and distinct metabolic repertoire
Wilson, M. C., Mori, T., Rückert, C., Uria, A. R., Helf, M. J., Takada, K., Gernert, C., Steffens, U. A. E., Heycke, N., Schmitt, S., et al. (2014) · Nature · doi:10.1038/nature12959 · Cited by 606
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Effects of actinobacteria on plant disease suppression and growth promotion
Palaniyandi, S. A., Yang, S. H., Zhang, L., & Suh, J.-W. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5206-1 · Cited by 452
Chemical ecology of antibiotic production by actinomycetes
van der Meij, A., Worsley, S. F., Hutchings, M. I., & van Wezel, G. P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux005 · Cited by 449
Self-citationStreptomyces as symbionts: an emerging and widespread theme?
Seipke, R. F., Kaltenpoth, M., & Hutchings, M. I. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00313.x · Cited by 417
Self-citationStreptomyces as a plant's best friend?
Viaene, T., Langendries, S., Beirinckx, S., Maes, M., & Goormachtig, S. (2016) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiw119 · Cited by 374
Prospects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Actinobacteria as mutualists: general healthcare for insects?
Kaltenpoth, M. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.09.006 · Cited by 283
THE MOLECULAR PHYLOGENY AND SYSTEMATICS OF THE ACTINOMYCETES
Embley, T. M., & Stackebrandt, E. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.001353 · Cited by 282
Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora
Ziemert, N., Lechner, A., Wietz, M., Millán-Aguiñaga, N., Chavarria, K. L., & Jensen, P. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324161111 · Cited by 278
Luo, Y., Huang, H., Liang, J., Wang, M., Lu, L., Shao, Z., Cobb, R. E., & Zhao, H. (2013) · Nature Communications · doi:10.1038/ncomms3894 · Cited by 259
Gulder, T. A. M., & Moore, B. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000728 · Cited by 246
Renwick, M. J., Brogan, D. M., & Mossialos, E. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2015.98 · Cited by 233
Natural products in soil microbe interactions and evolution
Traxler, M. F., & Kolter, R. (2015) · Natural Product Reports · doi:10.1039/c5np00013k · Cited by 223
Lincke, T., Behnken, S., Ishida, K., Roth, M., & Hertweck, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906114 · Cited by 215
Discovery of MRSA active antibiotics using primary sequence from the human microbiome
Chu, J., Vila-Farres, X., Inoyama, D., Ternei, M., Cohen, L. J., Gordon, E. A., Reddy, B. V. B., Charlop-Powers, Z., Zebroski, H. A., Gallardo-Macias, R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2207 · Cited by 206
ANTIBIOTIC SUBSTANCES PRODUCED BY PSEUDOMONAS AERUGINOSA
Hays, E. E., Wells, I. C., Katzman, P. A., Cain, C. K., Jacobs, F. A., Thayer, S. A., Doisy, E. A., Gaby, W. L., Roberts, E. C., MUIR, R. D., et al. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41580-8 · Cited by 133
The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology
Prescott, J. F. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.02.035 · Cited by 115
A 1,000-Year-Old Antimicrobial Remedy with Antistaphylococcal Activity
Harrison, F., Roberts, A. E. L., Gabrilska, R. A., Rumbaugh, K. P., Lee, C., & Diggle, S. P. (2015) · mBio · doi:10.1128/mbio.01129-15 · Cited by 110
Urban park soil microbiomes are a rich reservoir of natural product biosynthetic diversity
Charlop–Powers, Z., Pregitzer, C. C., Lemetre, C., Ternei, M. A., Maniko, J., Hover, B. M., Calle, P. Y., McGuire, K. L., Garbarino, J., Forgione, H. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615581113 · Cited by 109
A microbial factory for defensive kahalalides in a tripartite marine symbiosis
Zan, J., Li, Z., Tianero, M. D. B., Davis, J., Hill, R. T., & Donia, M. S. (2019) · Science · doi:10.1126/science.aaw6732 · Cited by 107
Chemical warfare between leafcutter ant symbionts and a co-evolved pathogen
Heine, D., Holmes, N. A., Worsley, S. F., Santos, A. C. A., Innocent, T. M., Scherlach, K., Patrick, E. H., Yu, D. W., Murrell, J. C., Vieria, P. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04520-1 · Cited by 106
Self-citationTime for a change: addressing R&D and commercialization challenges for antibacterials
Payne, D. J., Miller, L. F., Findlay, D. M., Anderson, J., & Marks, L. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0086 · Cited by 102
Zhang, X., Hindra, F., & Elliot, M. A. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.03.003 · Cited by 98
Clostridium difficile Drug Pipeline: Challenges in Discovery and Development of New Agents
Jarrad, A. M., Karoli, T., Blaskovich, M. A. T., Lyras, D., & Cooper, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5016846 · Cited by 97
Bioactivity-HiTES Unveils Cryptic Antibiotics Encoded in Actinomycete Bacteria
Moon, K., Xu, F. Y., Zhang, C., & Seyedsayamdost, M. R. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00049 · Cited by 81
Emmerich, R., & Löw, O. (1899) · Medical Microbiology and Immunology · doi:10.1007/bf02206499 · Cited by 71
Hoefler, B. C., Stubbendieck, R. M., Josyula, N., Moisan, S. M., Schulze, E. M., & Straight, P. D. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.08.008 · Cited by 53
Farrell, L., Lo, R., Wanford, J. J., Jenkins, A., Maxwell, A., & Piddock, L. J. V. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky208 · Cited by 49
Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology
Gelpi, A. H., Gilbertson, A., & Tucker, J. D. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051779 · Cited by 43
Microbial secondary metabolites and their impacts on insect symbioses
Klassen, J. L. (2014) · Current Opinion in Insect Science · doi:10.1016/j.cois.2014.08.004 · Cited by 40
After Venus, mercury: syphilis treatment in the UK before Salvarsan
Gelpi, A. H., & Tucker, J. D. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051778 · Cited by 12
Cited by
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Self-citationAntimicrobial Resistance (AMR)
Tang, K. W. K., Millar, B. C., & Moore, J. E. (2023) · British Journal of Biomedical Science · doi:10.3389/bjbs.2023.11387 · Cited by 1,009
Chaturvedi, P., Shukla, P., Giri, B. S., Chowdhary, P., Chandra, R., Gupta, P., & Pandey, A. (2021) · Environmental Research · doi:10.1016/j.envres.2020.110664 · Cited by 709
Metadata
- Authors
- Hutchings, M. I., Truman, A. W., & Wilkinson, B.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 51
- Pages
- 72-80
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2989135569
- Cited by
- 2,370
- References
- 47
- FWCI
- 29.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.